WAT (Waters) EBIT: $627 Mil (TTM As of Mar. 2026)


WAT Waters Corp WAT
92 GF Score
Price $369.18
GF Value $415.96
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Waters EBIT?

Waters WAT +3.35% 92 EBIT is $627 Mil as of Mar. 2026. GuruFocus rates WAT with a GF Score™ of 92/100 and a GF Value™ of $415.96 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Waters's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $-40 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $627 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Waters's annualized ROC % for the quarter that ended in Mar. 2026 was -1.11%. Waters's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -6.21%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Waters's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 1.52%.


Waters  (NYSE:WAT) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Waters's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-188 * ( 1 - 18.18% )/( (4337.15 + 23398)/ 2 )
=-153.8216/13867.575
=-1.11 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=5076.55 - 151.569 - ( 587.831 - max(0, 1239.499 - 2147.645+587.831))
=4337.15

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Waters's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-160/( ( (722.81 + max(811.406, 0)) + (1876 + max(1742, 0)) )/ 2 )
=-160/( ( 1534.216 + 3618 )/ 2 )
=-160/2576.108
=-6.21 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(828.844 + 572.371 + 158.599) - (151.569 + 266.54 + 330.299)
=811.406

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1753 + 1496 + 353) - (671 + 520 + 669)
=1742

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Waters's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=627.268/41356.253
=1.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Waters EBIT Related Terms


Waters EBIT Historical Data

* Premium members only.

The historical data trend for Waters's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Waters EBIT Chart

Waters Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 851.13 886.64 835.10 844.55 824.43

Waters Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 157.00 192.04 196.76 278.47 -40.00

WAT vs A, NTRA, IDXX: EBIT Comparison

For the Diagnostics & Research subindustry, Waters's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Waters EV-to-EBIT vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Waters's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Waters's EV-to-EBIT falls into.


WAT
92GF Score
Waters Corp WAT
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Waters EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $627 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $627 Mil mean?
Waters (WAT) has a EBIT of $627 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Waters.
Is Waters' EBIT too high?
Waters' current EBIT is $627 Mil. Overall, Waters has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Waters' EBIT compare to A and NTRA?
Waters' EBIT of $627 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Diagnostics & Research company?
A good EBIT depends on the Medical Diagnostics & Research industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Waters. Waters's current EBIT is $627 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Waters stock overvalued right now?
Based on GuruFocus' analysis, Waters (WAT) is currently considered Modestly Undervalued. The stock's GF Value™ is $415.96, compared to a current price of $369.18 — trading 11.2% below its estimated fair value. The current EBIT is $627 Mil. Waters' overall GF Score™ is 92/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Waters (WAT), the current EBIT is $627 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Waters (WAT) Overvalued in 2026?

Based on GuruFocus' analysis, Waters stock appears to be undervalued. The current stock price of $369.18 is trading 11.2% below its estimated GF Value™ of $415.96. GuruFocus considers Waters to be Modestly Undervalued.

Key valuation signals for WAT:

  • EBIT: $627 Mil
  • GF Value™: $415.96 vs. price of $369.18 (11.2% below fair value)
  • GF Score™: 92/100 with 6 warning signs

No single metric tells the full story. See the WAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Waters Business Description

Address 34 Maple Street, Milford, MA, USA, 01757
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.
92GF Score

Get the complete analysis for WAT

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$369.18
Price
$415.96
GF Value